Capricor Therapeutics, Inc. (CAPR)
24.51
+0.67
(+2.81%)
USD |
NASDAQ |
Jan 12, 16:00
24.28
-0.23
(-0.94%)
Pre-Market: 09:17
Capricor Therapeutics Research and Development Expense (Quarterly): 20.11M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.30M |
| Inovio Pharmaceuticals, Inc. | 12.98M |
| Perspective Therapeutics, Inc. | 19.56M |
| Arcturus Therapeutics Holdings, Inc. | 19.38M |
| Myomo, Inc. | 1.528M |